The best indicator for Mettler Toledo (MTD)
We backtested 20 indicators across daily, weekly and hourly charts on real Mettler Toledo (MTD) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Holy Grail Confluence
On the daily chart, this is the strongest risk-adjusted edge we found for Mettler Toledo (MTD) over ~28.5 years — trailing buy-and-hold by 8.3% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Holy Grail Confluence ✓ | Daily | 8.2% | 0.54 | -47.9% | 87.0% | 46 | -8.3% |
| 2 | SMA 50/200 Cross ✓ | Daily | 10.5% | 0.53 | -41.0% | 56.5% | 23 | -6.0% |
| 3 | Money Flow Index ✓ | Daily | 9.5% | 0.51 | -58.1% | 78.1% | 32 | -7.0% |
| 4 | Bollinger Mean-Reversion ✓ | Daily | 7.1% | 0.49 | -29.5% | 71.2% | 118 | -9.4% |
| 5 | RSI Trend (>50) ✓ | Weekly | 9.2% | 0.49 | -34.7% | 51.4% | 72 | -7.2% |
| 6 | Williams %R ✓ | Weekly | 8.0% | 0.49 | -42.8% | 73.7% | 38 | -8.4% |
| 7 | EMA 50/200 Cross ✓ | Daily | 9.0% | 0.47 | -45.4% | 38.1% | 21 | -7.5% |
| 8 | Donchian Midline ✓ | Weekly | 8.0% | 0.46 | -44.9% | 52.4% | 63 | -8.4% |
| 9 | EMA-10 Trend ✓ | Weekly | 7.8% | 0.45 | -43.6% | 53.9% | 128 | -8.6% |
| 10 | EMA 20/50 Cross ✓ | Weekly | 10.6% | 0.54 | -53.6% | 50.0% | 12 | -5.7% |
| 11 | EMA 20/50 Cross ✓ | Daily | 7.2% | 0.42 | -43.0% | 46.2% | 65 | -9.3% |
| 12 | MACD ✓ | Weekly | 6.7% | 0.42 | -59.8% | 48.3% | 60 | -9.7% |
| 13 | Heikin-Ashi Trend ✓ | Weekly | 6.5% | 0.4 | -50.6% | 50.6% | 253 | -9.9% |
| 14 | RSI Mean-Reversion ✓ | Daily | 4.2% | 0.37 | -28.8% | 73.7% | 38 | -12.3% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Mettler Toledo (MTD), Holy Grail Confluence on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.